GENinCode Plc (LON:GENI – Get Free Report) shares traded up 12.1% during trading on Tuesday . The stock traded as high as GBX 1.25 and last traded at GBX 1.21. 11,170,745 shares were traded during mid-day trading, an increase of 118% from the average session volume of 5,121,070 shares. The stock had previously closed at GBX 1.08.
GENinCode Price Performance
The stock has a 50 day moving average price of GBX 1.74 and a 200-day moving average price of GBX 2.33. The company has a debt-to-equity ratio of 9.28, a current ratio of 2.60 and a quick ratio of 15.89. The stock has a market capitalization of £3.48 million, a price-to-earnings ratio of -0.52 and a beta of 0.66.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Read More
- Five stocks we like better than GENinCode
- Unlocked: Elon Musk’s Next Big IPO
- This makes me furious
- The Foundation Behind Today’s Biggest Tech Trends
- Silver $500? The “Deficit Math” says it’s possible.
- Read this or regret it forever
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
